MusclePharm Corporation
MSLPQ
$0.00
$0.000.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 534.00K | 1.22M | 384.00K | 1.02M | 592.00K |
| Total Receivables | 9.28M | 6.39M | 7.33M | 5.56M | 6.22M |
| Inventory | 975.00K | 1.83M | 1.59M | 1.56M | 1.35M |
| Prepaid Expenses | 1.05M | 1.53M | 1.54M | 2.18M | 814.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.84M | 10.97M | 10.84M | 10.32M | 8.98M |
|
|
|||||
| Total Current Assets | 11.84M | 10.97M | 10.84M | 10.32M | 8.98M |
| Net Property, Plant & Equipment | 139.00K | 208.00K | 278.00K | 347.00K | 419.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 35.00K | 115.00K | 195.00K | 275.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 75.00K | 75.00K | 275.00K |
| Total Assets | 11.98M | 11.21M | 11.31M | 10.94M | 9.95M |
|
|
|||||
| Total Accounts Payable | 18.88M | 17.98M | 18.77M | 15.22M | 13.76M |
| Total Accrued Expenses | 4.55M | 3.84M | 4.70M | 3.86M | 3.63M |
| Short-term Debt | 17.08M | 11.48M | 6.09M | 7.76M | 6.45M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.56M | 5.67M | 5.78M | 3.30M | 3.49M |
| Total Finance Division Other Current Liabilities | 2.10M | 2.10M | 2.23M | 2.95M | 2.18M |
| Total Other Current Liabilities | 2.10M | 2.10M | 2.23M | 2.95M | 2.18M |
| Total Current Liabilities | 48.17M | 41.08M | 37.56M | 33.08M | 29.51M |
|
|
|||||
| Total Current Liabilities | 48.17M | 41.08M | 37.56M | 33.08M | 29.51M |
| Long-Term Debt | -- | -- | 820.00K | 643.00K | 804.00K |
| Short-term Debt | 17.08M | 11.48M | 6.09M | 7.76M | 6.45M |
| Capital Leases | -- | -- | -- | 119.00K | 233.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.86M | 2.33M | 2.74M | 3.37M | 3.73M |
| Total Liabilities | 50.03M | 43.40M | 41.12M | 37.21M | 34.27M |
|
|
|||||
| Common Stock & APIC | 183.82M | 183.39M | 178.99M | 178.60M | 178.29M |
| Retained Earnings | -211.84M | -205.54M | -198.76M | -194.83M | -192.58M |
| Treasury Stock & Other | -10.04M | -10.04M | -10.04M | -10.04M | -10.04M |
| Total Common Equity | -38.06M | -32.19M | -29.81M | -26.27M | -24.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.06M | -32.19M | -29.81M | -26.27M | -24.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.06M | -32.19M | -29.81M | -26.27M | -24.33M |
|
|
|||||
